跳至主要内容
临床试验/NCT04310969
NCT04310969已完成不适用

Clinical Effect of MiboFlo in Dry Eye Patients

Beijing Tongren Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2020年4月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
subjective symptom score

研究概览

简要总结

The aim of this prospective study is to compare the changes between the patients receiving traditional treatment and the patients with MiBoFlo, evaluating the effectiveness of MiBoFlo.

详细描述

The MiBoFlo Thermoflo uses a proprietary thermoelectric heat pump to help meibum maximize liquefaction, improving the preservation and function of the tear film's evaporative component. It supplies continuous controlled heat to the outer skin of the eyelids, absorbing deep into the tissue and breaks down the hardened oils in the meibomian glands. We are trying to find a effective, safe and economical therapy for dry eye patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age of older;
  • Meet the diagnostic criteria for dry eye developed by DEWS II: OSDI score≥15 points, TBUT≤10 minutes;
  • Meet the signs of meibomian gland dysfunction

排除标准

  • Had skin allergies or inflammation;
  • Had active ocular infection or inflammation;
  • Had history of ocular surgery, eyelid surgery or neurological paralysis within 6 months;
  • Had history of systemic disease affecting ocular surface function, such as Stevens-Johnson syndrome, Sjögren syndrome etc.

结局指标

主要结局

subjective symptom score

时间窗: 2 weeks

Ocular Surface Disease Index (OSDI©) questionnaire was chosen to assess subjective symptoms of dry eye, which can demonstrate sensitivity and specificity in distinguishing between normal subjects and patients with dry eye disease.

Meibomian Glands Yielding Liquid Secretion (MGYLS)

时间窗: 2 weeks

The total number of MGYLS was counted for both upper and lower lid of each eye.

Meibomian Glands Secretion (MGS)

时间窗: 2 weeks

The total number of MGYLS was counted for both upper and lower lid of each eye.

次要结局

  • Tear Meniscus Height(TMH)(2 weeks)
  • Non-invasive Keratograph Break-up Time(NIKBUT)(2 weeks)
  • Meibography(2 weeks)
  • Corneal Fluorescein Staining(CFS)(2 weeks)

研究者

发起方
Beijing Tongren Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Clinical Effect of MiboFlo in Dry Eye Patients | 临床试验